Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: DROXIDOPA — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the original application for a generic version of droxidopa, with Bionpharma Inc. as the manufacturer. The drug is used to treat neurogenic orthost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Droxidopa (Droxidopa)

Snippet

ORIG AP for DROXIDOPA (DROXIDOPA)